← Back to Search

Digital Meditation for Postoperative Pain After Cancer Surgery

Phase < 1
Recruiting
Led By Maggie Diller, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must have undergone open abdominal surgery for cancer
Patients must have the ability to understand the purposes and risks of the study and willingly give standard written informed consent for treatment established by each participating institution.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial is testing whether a digital meditation can help with post-operative pain control and stress after abdominal surgery for cancer.

Who is the study for?
This trial is for adults who've had open abdominal surgery for cancer, can read, own a smartphone with texting capabilities, and understand the study's risks. They must consent to treatment standards. It's not for those with conditions that rule out abdominal surgery or general anesthesia.Check my eligibility
What is being tested?
The trial is testing a digital meditation program delivered through text messages to help manage pain after cancer-related abdominal surgery. The goal is to see if guided meditation can reduce pain severity, cut down opioid use, and aid in recovery.See study design
What are the potential side effects?
Since this intervention involves mindfulness and meditation via texts rather than medication or invasive procedures, side effects are minimal but may include discomfort from focusing on pain during meditation or stress from technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had open surgery in my abdomen for cancer.
Select...
I understand the study's risks and purposes and agree to participate.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of intervention and mode of delivery
Incidence of adverse events
Secondary outcome measures
Intervention and mode of delivery utilizing the Client Satisfaction Survey (CSQ-8)
Intervention and mode of delivery utilizing the System Usability Scale (SUS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2 (Mindfulness Intervention)Experimental Treatment2 Interventions
Patients complete mindfulness intervention via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.
Group II: Arm I (Pain Survey)Active Control2 Interventions
Patients complete pain survey via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,634 Previous Clinical Trials
2,560,123 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,297 Total Patients Enrolled
Maggie Diller, MDPrincipal InvestigatorEmory University/Winship Cancer Institute

Media Library

Text Message-Based Navigation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05346692 — Phase < 1
Cancer Research Study Groups: Arm I (Pain Survey), Arm 2 (Mindfulness Intervention)
Cancer Clinical Trial 2023: Text Message-Based Navigation Intervention Highlights & Side Effects. Trial Name: NCT05346692 — Phase < 1
Text Message-Based Navigation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05346692 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Oct 2024